Steve Reeves

Title: The Innovative Contributions of Steve Reeves

Introduction

Steve Reeves is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of screening tools for anti-flea reagents. His work has implications for both veterinary medicine and vaccine design.

Latest Patents

Steve Reeves holds a patent for "Flea membrane binding site proteins as screening tools." This patent focuses on the cellular binding proteins present in the membranes of fleas, especially those found in the digestive tract. These proteins are useful for screening systemic anti-flea reagents and in designing vaccine formulations. Notably, the alpha-subunit of (Na+/K+)ATPase is highlighted in his patent. This protein, when expressed in recombinant host cells alongside the beta-subunit, is distributed on the membrane, allowing for the screening of candidates that can bind to these cells. Secondary screens are employed to determine the specificity of candidate reagents for flea proteins compared to similar proteins from other sources.

Career Highlights

Steve Reeves is currently associated with Paravax, Inc., where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in pest control and vaccine development.

Collaborations

Steve has collaborated with notable colleagues, including Miles Yamanaka and Beverly Dale, who contribute to the research and development efforts at Paravax, Inc.

Conclusion

Steve Reeves exemplifies the spirit of innovation in biotechnology through his patent and ongoing work. His contributions are paving the way for advancements in anti-flea treatments and vaccine formulations.